{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:19:27Z","timestamp":1791753567092,"version":"4.3.4"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40263-025-01241-0","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T18:53:08Z","timestamp":1762800788000},"page":"43-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cerebral Aspergillosis: Diagnostic Challenges, Therapeutic Strategies, and Future Research"],"prefix":"10.1007","volume":"40","author":[{"given":"Louise","family":"Chantelot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sitterl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Poir\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Danion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-4662","authenticated-orcid":false,"given":"Alexandra","family":"Serris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"1241_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jof3040055","volume":"3","author":"IMW Dewi","year":"2017","unstructured":"Dewi IMW, van de Veerdonk FL, Gresnigt MS. The multifaceted role of T-Helper responses in host defense against Aspergillus fumigatus. J Fungi (Basel). 2017;3:55.","journal-title":"J Fungi (Basel)."},{"key":"1241_CR2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","volume":"17","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007). Clin Microbiol Infect. 2011;17:1882\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1241_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/hupa.2002.30186","volume":"33","author":"BK Kleinschmidt-DeMasters","year":"2002","unstructured":"Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol. 2002;33:116\u201324.","journal-title":"Hum Pathol"},{"key":"1241_CR4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/clinids\/23.3.628","volume":"23","author":"L Pagano","year":"1996","unstructured":"Pagano L, Ricci P, Montillo M, Cenacchi A, Nosari A, Tonso A, et al. Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell\u2019Adulto Infection Program. Clin Infect Dis. 1996;23:628\u201330.","journal-title":"Clin Infect Dis"},{"key":"1241_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/jhin.2001.1170","volume":"50","author":"A Hori","year":"2002","unstructured":"Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect. 2002;50:175\u201382.","journal-title":"J Hosp Infect"},{"key":"1241_CR6","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","volume":"106","author":"S Schwartz","year":"2005","unstructured":"Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 2005;106:2641\u20135.","journal-title":"Blood"},{"key":"1241_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152475","volume":"11","author":"G Marzolf","year":"2016","unstructured":"Marzolf G, Sabou M, Lannes B, Cotton F, Meyronet D, Galanaud D, et al. Magnetic resonance imaging of cerebral aspergillosis: imaging and pathological correlations. PLoS ONE. 2016;11:e0152475.","journal-title":"PLoS ONE"},{"key":"1241_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jinf.2021.11.014","volume":"84","author":"A Serris","year":"2022","unstructured":"Serris A, Benzakoun J, Danion F, Porcher R, Sonneville R, Wolff M, et al. Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study nationwide CEREbral aspergillosis lesional study (CEREALS). J Infect. 2022;84:227\u201336.","journal-title":"J Infect"},{"key":"1241_CR9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.idnow.2021.04.002","volume":"51","author":"DS Meena","year":"2021","unstructured":"Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: a systematic review of 235 cases. Infect Dis Now. 2021;51:654\u201360.","journal-title":"Infect Dis Now"},{"key":"1241_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijid.2007.01.013","volume":"11","author":"J Dotis","year":"2007","unstructured":"Dotis J, Iosifidis E, Roilides E. Central nervous system aspergillosis in children: a systematic review of reported cases. Int J Infect Dis. 2007;11:381\u201393.","journal-title":"Int J Infect Dis"},{"key":"1241_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00330-002-1480-5","volume":"13","author":"A Guermazi","year":"2003","unstructured":"Guermazi A, Gluckman E, Tabti B, Miaux Y. Invasive central nervous system aspergillosis in bone marrow transplantation recipients: an overview. Eur Radiol. 2003;13:377\u201388.","journal-title":"Eur Radiol"},{"key":"1241_CR12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.12884","volume":"62","author":"A Candoni","year":"2019","unstructured":"Candoni A, Klimko N, Busca A, Di Blasi R, Shadrivova O, Cesaro S, et al. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases. Mycoses. 2019;62:252\u201360.","journal-title":"Mycoses"},{"issue":"6","key":"1241_CR13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"1241_CR14","first-page":"1597","volume":"20","author":"DR DeLone","year":"1999","unstructured":"DeLone DR, Goldstein RA, Petermann G, Salamat MS, Miles JM, Knechtle SJ, et al. Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am J Neuroradiol. 1999;20:1597\u2013604.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1241_CR15","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14394","volume":"26","author":"LM Grant","year":"2024","unstructured":"Grant LM, Vega PJT, Yaman RN, Girardo ME, Beam E, Razonable RR, et al. Brain abscess following solid organ transplantation: a 21-year retrospective study. Transpl Infect Dis. 2024;26:e14394.","journal-title":"Transpl Infect Dis"},{"key":"1241_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2022.05.019","volume":"85","author":"L van den Bogaart","year":"2022","unstructured":"van den Bogaart L, Lang BM, Rossi S, Neofytos D, Walti LN, Khanna N, et al. Central nervous system infections in solid organ transplant recipients: results from the Swiss Transplant Cohort Study. J Infect. 2022;85:1\u20137.","journal-title":"J Infect"},{"key":"1241_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","volume":"36","author":"N Singh","year":"2003","unstructured":"Singh N, Avery RK, Munoz P, Pruett TL, Alexander B, Jacobs R, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36:46\u201352.","journal-title":"Clin Infect Dis"},{"key":"1241_CR18","volume":"45","author":"L Gouzien","year":"2024","unstructured":"Gouzien L, Che D, Cassaing S, Lortholary O, Letscher-Bru V, Paccoud O, et al. Epidemiology and prognostic factors of mucormycosis in France (2012\u20132022): a cross-sectional study nested in a prospective surveillance programme. Lancet Reg Health. 2024;45:101010.","journal-title":"Lancet Reg Health"},{"key":"1241_CR19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176\u201383.","journal-title":"Clin Infect Dis"},{"key":"1241_CR20","doi-asserted-by":"crossref","DOI":"10.3390\/jof2020015","volume":"2","author":"J King","year":"2016","unstructured":"King J, Henriet SSV, Warris A. Aspergillosis in chronic granulomatous disease. J Fungi. 2016;2:15.","journal-title":"J Fungi"},{"issue":"17","key":"1241_CR21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89890","volume":"1","author":"N Rieber","year":"2016","unstructured":"Rieber N, Gazendam RP, Freeman AF, Hsu AP, Collar AL, Sugui JA, et al. Extrapulmonary Aspergillus infection in patients with CARD9 deficiency. JCI Insight. 2016;1(17):e89890.","journal-title":"JCI Insight"},{"key":"1241_CR22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaci.2018.05.009","volume":"142","author":"M Natarajan","year":"2018","unstructured":"Natarajan M, Hsu AP, Weinreich MA, Zhang Y, Niemela JE, Butman JA, et al. Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency. J Allergy Clin Immunol. 2018;142:993-997.e3.","journal-title":"J Allergy Clin Immunol"},{"key":"1241_CR23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","volume":"131","author":"D Ghez","year":"2018","unstructured":"Ghez D, Calleja A, Protin C, Baron M, Ledoux M-P, Damaj G, et al. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Blood. 2018;131:1955\u20139.","journal-title":"Blood"},{"key":"1241_CR24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3324\/haematol.2019.219220","volume":"105","author":"D Blez","year":"2020","unstructured":"Blez D, Blaize M, Soussain C, Boissonnas A, Meghraoui-Kheddar A, Menezes N, et al. Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus. Haematologica. 2020;105:478\u201389.","journal-title":"Haematologica"},{"key":"1241_CR25","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2017-12-823393","volume":"132","author":"A Bercusson","year":"2018","unstructured":"Bercusson A, Colley T, Shah A, Warris A, Armstrong-James D. Ibrutinib blocks Btk-dependent NF-\u0138B and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis. Blood. 2018;132:1985\u20138.","journal-title":"Blood"},{"key":"1241_CR26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176142","volume":"134","author":"JV Desai","year":"2024","unstructured":"Desai JV, Zarakas MA, Wishart AL, Roschewski M, Aufiero MA, Donk\u00f2 A, et al. BTK drives neutrophil activation for sterilizing antifungal immunity. J Clin Investig. 2024;134:e176142.","journal-title":"J Clin Investig"},{"key":"1241_CR27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/curroncol28010081","volume":"28","author":"O Alkharabsheh","year":"2021","unstructured":"Alkharabsheh O, Alsayed A, Morlote DM, Mehta A. Cerebral invasive aspergillosis in a case of chronic lymphocytic leukemia with bruton tyrosine kinase inhibitor. Curr Oncol. 2021;28:837\u201341.","journal-title":"Curr Oncol"},{"key":"1241_CR28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/bloodadvances.2021005621","volume":"6","author":"CS Tam","year":"2022","unstructured":"Tam CS, Dimopoulos M, Garcia-Sanz R, Trotman J, Opat S, Roberts AW, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6:1296\u2013308.","journal-title":"Blood Adv"},{"key":"1241_CR29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-261036","volume":"18","author":"M Elyas","year":"2025","unstructured":"Elyas M, Amer A. Cerebral aspergillosis in a patient with chronic lymphocytic leukaemia complicated by Evans syndrome. BMJ Case Rep. 2025;18:e261036.","journal-title":"BMJ Case Rep"},{"key":"1241_CR30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","volume":"12","author":"S Feys","year":"2024","unstructured":"Feys S, Carvalho A, Clancy CJ, Gangneux J-P, Hoenigl M, Lagrou K, et al. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir Med. 2024;12:728\u201342.","journal-title":"Lancet Respir Med"},{"key":"1241_CR31","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00134-021-06440-z","volume":"47","author":"V De Villiers De La Noue","year":"2021","unstructured":"De Villiers De La Noue V, Dobanton B, Rosman J, Mateu P. Intracerebral Aspergillus fumigatus abscess and SARS-CoV-2. Intensive Care Med. 2021;47:1032\u20133.","journal-title":"Intensive Care Med"},{"key":"1241_CR32","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/lary.29632","volume":"131","author":"NA El-Kholy","year":"2021","unstructured":"El-Kholy NA, El-Fattah AMA, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity. Laryngoscope. 2021;131:2652\u20138.","journal-title":"Laryngoscope"},{"key":"1241_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3947\/ic.2013.45.2.225","volume":"45","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Kim M-K, Kang CK, Jun KI, Bang J-H, Park S-W, et al. A case of acute cerebral aspergillosis complicating influenza A\/H1N1pdm 2009. Infect Chemother. 2013;45:225\u20139.","journal-title":"Infect Chemother"},{"key":"1241_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijid.2022.05.056","volume":"122","author":"E Haddad","year":"2022","unstructured":"Haddad E, Fekkar A, Bonnin S, Shor N, Seilhean D, Plu I, et al. Cerebral vasculitis due to Aspergillus spp. in immunocompromised patients: literature review. Int J Infect Dis. 2022;122:244\u201351.","journal-title":"Int J Infect Dis"},{"key":"1241_CR35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mmcr.2017.06.006","volume":"18","author":"N Cicek","year":"2017","unstructured":"Cicek N, Yildiz N, Kadayifci EK, Gokce I, Alpay H. Invasive aspergillosis in a patient with end stage renal disease. Med Mycol Case Rep. 2017;18:12\u20134.","journal-title":"Med Mycol Case Rep"},{"key":"1241_CR36","volume":"95","author":"H-J Tang","year":"2016","unstructured":"Tang H-J, Liu W-L, Chang TC, Li M-C, Ko W-C, Wu C-J, et al. Multiple brain abscesses due to Aspergillus fumigatus in a patient with liver cirrhosis. Medicine (Baltimore). 2016;95:e2813.","journal-title":"Medicine (Baltimore)"},{"key":"1241_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00005792-200007000-00008","volume":"79","author":"E Mylonakis","year":"2000","unstructured":"Mylonakis E, Paliou M, Sax PE, Skolnik PR, Baron MJ, Rich JD. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review. Medicine (Baltimore). 2000;79:269\u201380.","journal-title":"Medicine (Baltimore)"},{"key":"1241_CR38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1469-0691.2006.01512.x","volume":"12","author":"AC Pasqualotto","year":"2006","unstructured":"Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12:1060\u201376.","journal-title":"Clin Microbiol Infect"},{"key":"1241_CR39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jinf.2012.11.003","volume":"66","author":"S Antinori","year":"2013","unstructured":"Antinori S, Corbellino M, Meroni L, Resta F, Sollima S, Tonolini M, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect. 2013;66:218\u201338.","journal-title":"J Infect"},{"key":"1241_CR40","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","volume":"91","author":"TK Kourkoumpetis","year":"2012","unstructured":"Kourkoumpetis TK, Desalermos A, Muhammed M, Mylonakis E. Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore). 2012;91:328\u201336.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 1","key":"1241_CR41","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/13693780600897989","volume":"44","author":"Y Kamai","year":"2006","unstructured":"Kamai Y, Chiang LY, Lopes Bezerra LM, Doedt T, Lossinsky AS, Sheppard DC, et al. Interactions of Aspergillus fumigatus with vascular endothelial cells. Med Mycol. 2006;44(Suppl 1):S115-117.","journal-title":"Med Mycol"},{"key":"1241_CR42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/iai.43.1.320-325.1984","volume":"43","author":"MH Kothary","year":"1984","unstructured":"Kothary MH, Chase T, Macmillan JD. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun. 1984;43:320\u20135.","journal-title":"Infect Immun"},{"key":"1241_CR43","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz392","volume":"6","author":"JS Little","year":"2019","unstructured":"Little JS, Cheng MP, Hsu L, Corrales CE, Marty FM. Invasive fungal carotiditis: a rare manifestation of cranial invasive fungal disease: case series and systematic review of the literature. Open Forum Infect Dis. 2019;6:ofz392.","journal-title":"Open Forum Infect Dis"},{"key":"1241_CR44","volume":"45","author":"A Hot","year":"2007","unstructured":"Hot A, Mazighi M, Lecuit M, Poir\u00e9e S, Viard J-P, Loulergue P, et al. Fungal internal carotid artery aneurysms: successful embolization of an Aspergillus-associated case and review. Clin Infect Dis. 2007;45:e156\u2013161.","journal-title":"Clin Infect Dis"},{"key":"1241_CR45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s003300100957","volume":"12","author":"A Guermazi","year":"2002","unstructured":"Guermazi A, Benchaib N, Zagdanski AM, Hocqueloux L, Rili M, Molina JM, et al. Cerebral and spinal cord involvement resulting from invasive aspergillosis. Eur Radiol. 2002;12:147\u201350.","journal-title":"Eur Radiol"},{"key":"1241_CR46","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27806","volume":"66","author":"M Lauten","year":"2019","unstructured":"Lauten M, Attarbaschi A, Cario G, D\u00f6ring M, Moser O, M\u00fccke U, et al. Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: analysis of 29 contemporary patients. Pediatr Blood Cancer. 2019;66:e27806.","journal-title":"Pediatr Blood Cancer"},{"key":"1241_CR47","doi-asserted-by":"crossref","unstructured":"Groll AH, Pana D, Lanternier F, Mesini A, Ammann RA, Averbuch D, et al. 8th European Conference on infections in leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021;22:e254\u201369.","DOI":"10.1016\/S1470-2045(20)30723-3"},{"key":"1241_CR48","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s15010-017-1072-6","volume":"45","author":"C Lass-Fl\u00f6rl","year":"2017","unstructured":"Lass-Fl\u00f6rl C, Aigner M, Nachbaur D, Eschertzhuber S, Bucher B, Geltner C, et al. Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience. Infection. 2017;45:867\u201375.","journal-title":"Infection"},{"key":"1241_CR49","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cmi.2024.05.013","volume":"30","author":"AS Komorowski","year":"2024","unstructured":"Komorowski AS, Hall CW, Atwal S, Johnstone R, Walker R, Mertz D, et al. Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis. Clin Microbiol Infect. 2024;30:1244\u201353.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1241_CR50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/JCM.02913-15","volume":"54","author":"GM Chong","year":"2016","unstructured":"Chong GM, Maertens JA, Lagrou K, Driessen GJ, Cornelissen JJ, Rijnders BJA. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol. 2016;54(2):428\u201331.","journal-title":"J Clin Microbiol"},{"key":"1241_CR51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/mmy\/myx091","volume":"56","author":"RA Barnes","year":"2018","unstructured":"Barnes RA, White PL, Morton CO, Rogers TR, Cruciani M, Loeffler J, et al. Diagnosis of aspergillosis by PCR: clinical considerations and technical tips. Med Mycol. 2018;56:60\u201372.","journal-title":"Med Mycol"},{"key":"1241_CR52","doi-asserted-by":"crossref","first-page":"889.e1","DOI":"10.1016\/j.cmi.2017.06.012","volume":"23","author":"S Imbert","year":"2017","unstructured":"Imbert S, Brossas J-Y, Palous M, Joly I, Meyer I, Fekkar A. Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clin Microbiol Infect. 2017;23:889.e1-889.e4.","journal-title":"Clin Microbiol Infect"},{"key":"1241_CR53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056706","volume":"8","author":"M Reinwald","year":"2013","unstructured":"Reinwald M, Buchheidt D, Hummel M, Duerken M, Bertz H, Schwerdtfeger R, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS ONE. 2013;8:e56706.","journal-title":"PLoS ONE"},{"key":"1241_CR54","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1038\/s41598-019-49426-0","volume":"9","author":"T Lehrnbecher","year":"2019","unstructured":"Lehrnbecher T, Rath PM, Attarbaschi A, Cario G, D\u00f6ring M, Moser O, et al. Galactomannan and PCR in the central nervous system to detect invasive mold disease\u2014a retrospective analysis in immunocompromised children. Sci Rep. 2019;9:12950.","journal-title":"Sci Rep"},{"key":"1241_CR55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jpids\/piv014","volume":"5","author":"CM Salvatore","year":"2016","unstructured":"Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA, et al. (1\u21923)-\u03b2-d-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatr Infect Dis Soc. 2016;5:277\u201386.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"1241_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e01022","volume":"23","author":"S Zayet","year":"2021","unstructured":"Zayet S, Zaghdoudi A, Ammari L, Kilani B, Tiouiri Benaissa H. Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: a case report. IDCases. 2021;23:e01022.","journal-title":"IDCases"},{"key":"1241_CR57","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1186\/s12879-023-08483-7","volume":"23","author":"A Amanati","year":"2023","unstructured":"Amanati A, Lotfi M, Abdolkarimi B, Karimi Rouzbahani A, Mahmoudvand G. Evolution of neuroimaging findings in angioinvasive cerebral aspergillosis in a pediatric patient with leukemia during long-term observation. BMC Infect Dis. 2023;23:811.","journal-title":"BMC Infect Dis"},{"key":"1241_CR58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00062-014-0305-7","volume":"24","author":"J Starkey","year":"2014","unstructured":"Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217\u201330.","journal-title":"Clin Neuroradiol"},{"key":"1241_CR59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00234-007-0242-0","volume":"49","author":"C Mueller-Mang","year":"2007","unstructured":"Mueller-Mang C, Castillo M, Mang TG, Cartes-Zumelzu F, Weber M, Thurnher MM. Fungal versus bacterial brain abscesses: is diffusion-weighted MR imaging a useful tool in the differential diagnosis? Neuroradiology. 2007;49:651\u20137.","journal-title":"Neuroradiology"},{"key":"1241_CR60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/mmy\/myw118","volume":"55","author":"TK Chen","year":"2017","unstructured":"Chen TK, Groncy PK, Javahery R, Chai RY, Nagpala P, Finkelman M, et al. Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1 \u2192 3)-\u03b2-d-glucan. Med Mycol. 2017;55:109\u201317.","journal-title":"Med Mycol"},{"key":"1241_CR61","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.medin.2022.01.008","volume":"47","author":"A \u00c1lvarez M\u00e9ndez","year":"2023","unstructured":"\u00c1lvarez M\u00e9ndez A, Castro Bournissen L, L\u00f3pez Gil MJ. Aspergillus spp ventriculitis: uncommon cause of altered level of consciousness. Med Intensiva (Engl Ed). 2023;47:368\u201370.","journal-title":"Med Intensiva (Engl Ed)."},{"key":"1241_CR62","volume":"59","author":"VD Mereuta","year":"2023","unstructured":"Mereuta VD, Sava A, Stan CI, Eva L, Dumitrescu GF, Dobrin N, et al. Cervico-dorsal intramedullary spinal cord abscess with Aspergillus fumigates following pulmonary infection in an immunocompetent patient. Medicina (Kaunas). 2023;59:806.","journal-title":"Medicina (Kaunas)"},{"key":"1241_CR63","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1038\/s41591-024-03275-1","volume":"30","author":"P Benoit","year":"2024","unstructured":"Benoit P, Brazer N, de Lorenzi-Tognon M, Kelly E, Servellita V, Oseguera M, et al. Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections. Nat Med. 2024;30:3522\u201333.","journal-title":"Nat Med"},{"key":"1241_CR64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1556\/030.2025.02528","volume":"72","author":"W Lu","year":"2025","unstructured":"Lu W, Ji R, Li W. Invasive pulmonary and central nervous system aspergillosis: a case report and literature review. Acta Microbiol Immunol Hung. 2025;72:9\u201315.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"1241_CR65","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12879-025-10884-9","volume":"25","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Hu X, Wang J, Wang N. Invasive cerebral aspergillosis in a pregnant woman: a rare case of intracranial giant granuloma. BMC Infect Dis. 2025;25:478.","journal-title":"BMC Infect Dis"},{"key":"1241_CR66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.leu.2404504","volume":"21","author":"L Potenza","year":"2007","unstructured":"Potenza L, Barozzi P, Vallerini D, Bosco R, Quadrelli C, Mediani L, et al. Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates. Leukemia. 2007;21:578\u201381.","journal-title":"Leukemia"},{"key":"1241_CR67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306728","volume":"19","author":"F Bettelli","year":"2024","unstructured":"Bettelli F, Vallerini D, Lagreca I, Barozzi P, Riva G, Nasillo V, et al. Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients. PLoS ONE. 2024;19:e0306728.","journal-title":"PLoS ONE"},{"key":"1241_CR68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","volume":"27","author":"T Felton","year":"2014","unstructured":"Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev. 2014;27:68\u201388.","journal-title":"Clin Microbiol Rev"},{"key":"1241_CR69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijantimicag.2006.04.006","volume":"28","author":"T Elter","year":"2006","unstructured":"Elter T, Sieniawski M, Gossmann A, Wickenhauser C, Schr\u00f6der U, Seifert H, et al. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman. Int J Antimicrob Agents. 2006;28:262\u20135.","journal-title":"Int J Antimicrob Agents"},{"key":"1241_CR70","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/AAC.00949-10","volume":"55","author":"S Weiler","year":"2011","unstructured":"Weiler S, Fiegl D, MacFarland R, Stienecke E, Bellmann-Weiler R, Dunzendorfer S, et al. Human tissue distribution of voriconazole. Antimicrob Agents Chemother. 2011;55:925\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR71","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","volume":"37","author":"I Lutsar","year":"2003","unstructured":"Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis. 2003;37:728\u201332.","journal-title":"Clin Infect Dis"},{"key":"1241_CR72","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/422526","volume":"39","author":"E Denes","year":"2004","unstructured":"Denes E, Pichon N, Debette-Gratien M, Bouteille B, Gaulier JM. Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus. Clin Infect Dis. 2004;39:603\u20134.","journal-title":"Clin Infect Dis"},{"key":"1241_CR73","volume":"63","author":"A Lee","year":"2019","unstructured":"Lee A, Prideaux B, Lee MH, Zimmerman M, Dolgov E, Perlin DS, et al. Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease. Antimicrob Agents Chemother. 2019;63:e00524\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR74","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02474-18","volume":"63","author":"C Rouzaud","year":"2019","unstructured":"Rouzaud C, Jullien V, Herbrecht A, Palmier B, Lapusan S, Morgand M, et al. Isavuconazole diffusion in infected human brain. Antimicrob Agents Chemother. 2019;63:e02474\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR75","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkz050","volume":"74","author":"F Lamoth","year":"2019","unstructured":"Lamoth F, Mercier T, Andr\u00e9 P, Pagani JL, Pantet O, Maduri R, et al. Isavuconazole brain penetration in cerebral aspergillosis. J Antimicrob Chemother. 2019;74:1751\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR76","doi-asserted-by":"crossref","unstructured":"Serris A, Rautemaa-Richardson R, Laranjinha JD, Candoni A, Garcia-Vidal C, Alastruey-Izquierdo A, et al. European Study of Cerebral Aspergillosis treated with Isavuconazole (ESCAI): a study by the ESCMID Fungal Infection Study Group. Clin Infect Dis. 2024;79(4):936\u201343.","DOI":"10.1093\/cid\/ciae371"},{"key":"1241_CR77","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1128\/AAC.00172-10","volume":"54","author":"E Calvo","year":"2010","unstructured":"Calvo E, Pastor FJ, Rodr\u00edguez MM, Pujol I, Guarro J. Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii. Antimicrob Agents Chemother. 2010;54:4074\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR78","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/AAC.01284-09","volume":"54","author":"E Calvo","year":"2010","unstructured":"Calvo E, Pastor FJ, Rodr\u00edguez MM, Mayayo E, Salas V, Guarro J. Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole. Antimicrob Agents Chemother. 2010;54:919\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR79","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkq385","volume":"66","author":"A Calcagno","year":"2011","unstructured":"Calcagno A, Baietto L, De Rosa FG, Tettoni MC, Libanore V, Bertucci R, et al. Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis. J Antimicrob Chemother. 2011;66:224\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/bmt.2009.17","volume":"44","author":"M Reinwald","year":"2009","unstructured":"Reinwald M, Uharek L, Lampe D, Grobosch T, Thiel E, Schwartz S. Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis. Bone Marrow Transplant. 2009;44:269\u201370.","journal-title":"Bone Marrow Transplant"},{"key":"1241_CR81","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jac\/dkn409","volume":"62","author":"MJGT R\u00fcping","year":"2008","unstructured":"R\u00fcping MJGT, Albermann N, Ebinger F, Burckhardt I, Beisel C, M\u00fcller C, et al. Posaconazole concentrations in the central nervous system. J Antimicrob Chemother. 2008;62:1468\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR82","first-page":"e01626","volume":"63","author":"V Petraitis","year":"2019","unstructured":"Petraitis V, Petraitiene R, Valdez JM, Pyrgos V, Lizak MJ, Klaunberg BA, et al. Amphotericin B penetrates into the central nervous system through focal disruption of the blood brain barrier in experimental hematogenous candida meningoencephalitis. Antimicrob Agents Chemother. 2019;63:e01626-e1719 (AAC.01626-19).","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR83","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jac\/dkl141","volume":"57","author":"H Vogelsinger","year":"2006","unstructured":"Vogelsinger H, Weiler S, Djanani A, Kountchev J, Bellmann-Weiler R, Wiedermann CJ, et al. Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion. J Antimicrob Chemother. 2006;57:1153\u201360.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR84","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00090-17","volume":"61","author":"J Lestner","year":"2017","unstructured":"Lestner J, McEntee L, Johnson A, Livermore J, Whalley S, Schwartz J, et al. Experimental models of short courses of liposomal amphotericin B for induction therapy for cryptococcal meningitis. Antimicrob Agents Chemother. 2017;61:e00090\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR85","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/jac\/dku148","volume":"69","author":"V Strenger","year":"2014","unstructured":"Strenger V, Meinitzer A, Donnerer J, Hofer N, Dornbusch HJ, Wanz U, et al. Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B. J Antimicrob Chemother. 2014;69:2522\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR86","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00275-20","volume":"64","author":"J Marx","year":"2020","unstructured":"Marx J, Welte R, Gasperetti T, Moser P, Beer R, Ortler M, et al. Anidulafungin and micafungin concentrations in cerebrospinal fluid and in cerebral cortex. Antimicrob Agents Chemother. 2020;64:e00275\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR87","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02753-21","volume":"10","author":"I Ullmann","year":"2022","unstructured":"Ullmann I, Aregger A, Leib SL, Zimmerli S. Caspofungin cerebral penetration and therapeutic efficacy in experimental cerebral aspergillosis. Microbiol Spectr. 2022;10:e0275321.","journal-title":"Microbiol Spectr"},{"key":"1241_CR88","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.02719-14","volume":"58","author":"F R\u00e9miniac","year":"2014","unstructured":"R\u00e9miniac F, Sonneville R, Massias L, Chochillon C, Wolff M. Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid. Antimicrob Agents Chemother. 2014;58:3568\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR89","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1186\/s12879-024-10143-3","volume":"24","author":"Y Vanbiervliet","year":"2024","unstructured":"Vanbiervliet Y, Van Nieuwenhuyse T, Aerts R, Lagrou K, Spriet I, Maertens J. Review of the novel antifungal drug olorofim (F901318). BMC Infect Dis. 2024;24:1256.","journal-title":"BMC Infect Dis"},{"key":"1241_CR90","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01795-20","volume":"65","author":"R Petraitiene","year":"2021","unstructured":"Petraitiene R, Petraitis V, Maung BBW, Mansbach RS, Hodges MR, Finkelman MA, et al. Efficacy and pharmacokinetics of fosmanogepix (APX001) in the treatment of candida endophthalmitis and hematogenous meningoencephalitis in nonneutropenic rabbits. Antimicrob Agents Chemother. 2021;65:e01795\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR91","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01184-19","volume":"63","author":"F Barde","year":"2019","unstructured":"Barde F, Billaud E, Goldwirt L, Horodyckid C, Jullien V, Lanternier F, et al. Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis. Antimicrob Agents Chemother. 2019;63:e01184\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR92","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000095820","volume":"52","author":"K Takemoto","year":"2006","unstructured":"Takemoto K, Yamamoto Y, Ueda Y. Influence of the progression of cryptococcal meningitis on brain penetration and efficacy of Am Bisome in a murine model. Chemotherapy. 2006;52:271\u20138.","journal-title":"Chemotherapy"},{"key":"1241_CR93","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/AAC.01328-10","volume":"55","author":"AM Flattery","year":"2011","unstructured":"Flattery AM, Hickey E, Gill CJ, Powles MA, Misura AS, Galgoci AM, et al. Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis. Antimicrob Agents Chemother. 2011;55:3491\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR94","volume":"61","author":"A-H Schmitt-Hoffmann","year":"2017","unstructured":"Schmitt-Hoffmann A-H, Kato K, Townsend R, Potchoiba MJ, Hope WW, Andes D, et al. Tissue distribution and elimination of isavuconazole following single and repeat oral-dose administration of isavuconazonium sulfate to rats. Antimicrob Agents Chemother. 2017;61:e01292\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR95","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01735-19","volume":"64","author":"S Alkhazraji","year":"2020","unstructured":"Alkhazraji S, Gebremariam T, Alqarihi A, Gu Y, Mamouei Z, Singh S, et al. Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis. Antimicrob Agents Chemother. 2020;64:e01735\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR96","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/mmy\/myz083","volume":"58","author":"MR Davis","year":"2020","unstructured":"Davis MR, Donnelley MA, Thompson GR. Ibrexafungerp: a novel oral glucan synthase inhibitor. Med Mycol. 2020;58:579\u201392.","journal-title":"Med Mycol"},{"issue":"Suppl 1","key":"1241_CR97","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1-38.","journal-title":"Clin Microbiol Infect"},{"key":"1241_CR98","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","volume":"102","author":"F Tissot","year":"2017","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 2017;102:433\u201344.","journal-title":"Haematologica"},{"key":"1241_CR99","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1-60.","journal-title":"Clin Infect Dis"},{"key":"1241_CR100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J-W, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408\u201315.","journal-title":"N Engl J Med"},{"key":"1241_CR101","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","volume":"387","author":"JA Maertens","year":"2016","unstructured":"Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387:760\u20139.","journal-title":"Lancet"},{"key":"1241_CR102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0609.2005.00500.x","volume":"75","author":"A Candoni","year":"2005","unstructured":"Candoni A, Mestroni R, Damiani D, Tiribelli M, Michelutti A, Silvestri F, et al. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. Eur J Haematol. 2005;75:227\u201333.","journal-title":"Eur J Haematol"},{"key":"1241_CR103","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289\u201397.","journal-title":"Clin Infect Dis"},{"key":"1241_CR104","doi-asserted-by":"crossref","DOI":"10.1111\/j.1439-0507.2010.01947.x","volume":"54","author":"OA Cornely","year":"2011","unstructured":"Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Dellow E, Herbrecht R, et al. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC\/MSG 2008 definitions of invasive mould disease. Mycoses. 2011;54:e449\u2013455.","journal-title":"Mycoses"},{"key":"1241_CR105","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","volume":"45","author":"R Herbrecht","year":"2010","unstructured":"Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, et al. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant. 2010;45:1227\u201333.","journal-title":"Bone Marrow Transplant"},{"key":"1241_CR106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","volume":"162","author":"KA Marr","year":"2015","unstructured":"Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, et al. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med. 2015;162:81\u20139.","journal-title":"Ann Intern Med"},{"key":"1241_CR107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2014.07.007","volume":"28","author":"AA Panackal","year":"2014","unstructured":"Panackal AA, Parisini E, Proschan M. Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2014;28:80\u201394.","journal-title":"Int J Infect Dis"},{"key":"1241_CR108","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1038\/s41467-024-54568-5","volume":"15","author":"MJ Bottery","year":"2024","unstructured":"Bottery MJ, van Rhijn N, Chown H, Rhodes JL, Celia-Sanchez BN, Brewer MT, et al. Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance. Nat Commun. 2024;15:10654.","journal-title":"Nat Commun"},{"key":"1241_CR109","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","volume":"68","author":"PP Lestrade","year":"2019","unstructured":"Lestrade PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, van der Velden WJFM, Kuiper EJ, et al. Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study. Clin Infect Dis. 2019;68:1463\u201371.","journal-title":"Clin Infect Dis"},{"key":"1241_CR110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","volume":"21\u201322","author":"PE Verweij","year":"2015","unstructured":"Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Br\u00fcggemann RJ, Chowdhary A, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Update. 2015;21\u201322:30\u201340.","journal-title":"Drug Resist Update"},{"key":"1241_CR111","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dku364","volume":"70","author":"J van Ingen","year":"2015","unstructured":"van Ingen J, van der Lee HA, Rijs TAJ, Zoll J, Leenstra T, Melchers WJG, et al. Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in the Netherlands. J Antimicrob Chemother. 2015;70:178\u201381.","journal-title":"J Antimicrob Chemother"},{"key":"1241_CR112","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00474-21","volume":"65","author":"A Pouvaret","year":"2021","unstructured":"Pouvaret A, Dur\u00e9ault A, Garcia-Hermoso D, Serris A, Cohen JF, Guery R, et al. Combined high-dose caspofungin and liposomal amphotericin B for treatment of azole-resistant cerebral aspergillosis. Antimicrob Agents Chemother. 2021;65:e0047421.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR113","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1128\/AAC.00491-08","volume":"52","author":"PE Verweij","year":"2008","unstructured":"Verweij PE, Te Dorsthorst DTA, Janssen WHP, Meis JFGM, Mouton JW. In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus. Antimicrob Agents Chemother. 2008;52:4483\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR114","volume":"6","author":"KJ Shaw","year":"2020","unstructured":"Shaw KJ, Ibrahim AS. Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections. J Fungi. 2020;6:239.","journal-title":"J Fungi"},{"key":"1241_CR115","doi-asserted-by":"crossref","unstructured":"Hodges MR, Tawadrous M, Cornely OA, Thompson GR, Slavin MA, Maertens JA, et al. Fosmanogepix for the treatment of invasive mold diseases caused by Aspergillus Species and rare molds: a phase 2, open-label study (AEGIS). Clin Infect Dis. 2025;ciaf185.","DOI":"10.1093\/cid\/ciaf185"},{"key":"1241_CR116","volume":"62","author":"NP Wiederhold","year":"2018","unstructured":"Wiederhold NP, Najvar LK, Jaramillo R, Olivo M, Birch M, Law D, et al. The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis. Antimicrob Agents Chemother. 2018;62:e00999\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"1241_CR117","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/cid\/ciad309","volume":"77","author":"DJ Winston","year":"2023","unstructured":"Winston DJ, Young PA, Schlamm HT, Schiller GJ. Fosmanogepix therapy of disseminated fusarium infection. Clin Infect Dis. 2023;77:848\u201350.","journal-title":"Clin Infect Dis"},{"key":"1241_CR118","doi-asserted-by":"crossref","unstructured":"Camargo JF, Jabr R, Anderson AD, Lekakis L, Diaz-Paez M, Briski LM, et al. Successful treatment of disseminated disease due to highly resistant Aspergillus calidoustus with a novel antifungal therapy. Antimicrob Agents Chemother. 2022;66(3):e02206-21.","DOI":"10.1128\/aac.02206-21"},{"key":"1241_CR119","doi-asserted-by":"crossref","unstructured":"Gebremariam T, Gu Y, Alkhazraji S, Youssef E, Shaw KJ, Ibrahim AS. The combination treatment of fosmanogepix and liposomal amphotericin B is superior to monotherapy in treating experimental invasive mold infections. Antimicrob Agents Chemother. 2022;66:e00380-22.","DOI":"10.1128\/aac.00380-22"},{"key":"1241_CR120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.wneu.2021.01.033","volume":"149","author":"HB Pajer","year":"2021","unstructured":"Pajer HB, Asher AM, Gelinne A, Northam W, van Duin D, Quinsey CS. Impact of surgical and medical treatment on survival of patients with cerebral aspergillosis: systematic review of the literature. World Neurosurg. 2021;149:244-248.e13.","journal-title":"World Neurosurg"},{"key":"1241_CR121","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","volume":"100","author":"H Hebart","year":"2002","unstructured":"Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100:4521\u20138.","journal-title":"Blood"},{"key":"1241_CR122","volume":"2012","author":"C Estrada","year":"2012","unstructured":"Estrada C, Desai AG, Chirch LM, Suh H, Seidman R, Darras F, et al. Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma. Case Rep Transplant. 2012;2012:493758.","journal-title":"Case Rep Transplant"},{"key":"1241_CR123","first-page":"1359","volume":"80","author":"M Mezidi","year":"2014","unstructured":"Mezidi M, Belafia F, Nougaret S, Pageaux GP, Conseil M, Panaro F, et al. Interferon gamma in association with immunosuppressive drugs withdrawal and antifungal combination as a rescue therapy for cerebral invasive Aspergillosis in a liver transplant recipient. Minerva Anestesiol. 2014;80:1359\u201360.","journal-title":"Minerva Anestesiol"},{"key":"1241_CR124","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","volume":"106","author":"K Perruccio","year":"2005","unstructured":"Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 2005;106:4397\u2013406.","journal-title":"Blood"},{"key":"1241_CR125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1209","volume":"14","author":"M Seif","year":"2022","unstructured":"Seif M, Kakoschke TK, Ebel F, Bellet MM, Trinks N, Renga G, et al. Car T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med. 2022;14:eabh1209.","journal-title":"Sci Transl Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01241-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01241-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:03:09Z","timestamp":1767646989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01241-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01241-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no potential conflicts in relation with this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Each author contributed by writing specific sections of the review. FD and AS critically revised the entire manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}